Under the deal, Exonics equity holders will receive $245m (£192m) upfront payment from Vertex, as well as potential future payments based on the achievement of specified development and
The post Vertex Pharmaceuticals to buy US firm Exonics Therapeutics appeared first on Pharmaceutical Business review.
Original Article: Vertex Pharmaceuticals to buy US firm Exonics Therapeutics